DCI
ROIV icon

Data Collective IV’s Roivant Sciences ROIV Stock Holding History

Data Collective IV’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,875
Closed -$58.6K – 4
2025
Q3 		$58.6K Hold
3,875
– – 0.09% 4
2025
Q2 		$43.7K Hold
3,875
– – 0.03% 5
2025
Q1 		$39.1K Hold
3,875
– – 0.05% 5
2024
Q4 		$45.8K Hold
3,875
– – 0.02% 6
2024
Q3 		$44.7K Hold
3,875
– – 0.03% 6
2024
Q2 		$41K Hold
3,875
– – 0.03% 6
2024
Q1 		$40.8K Hold
3,875
– – 0.04% 5
2023
Q4 		$43.5K Hold
3,875
– – 0.04% 5
2023
Q3 		$45.3K Hold
3,875
– – 0.04% 5
2023
Q2 		$39.1K Hold
3,875
– – 0.03% 6
2023
Q1 		$28.6K Sell
3,875
-21,965
-85% -$181K 0.03% 6
2022
Q4 		$206K Buy
+25,840
New +$144K 0.22% 6

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Data Collective IV's ROIV Position: Q4 2025 in Review

Data Collective IV sold out of Roivant Sciences (ROIV) in Q4 2025, closing a stake of 3,875 shares — an estimated $58.6K sold.

Data Collective IV first reported a position in ROIV in Q4 2022 and held it in 12 quarters. The position peaked at $206K in Q4 2022. 396 funds tracked by Wall St. Rank hold ROIV as of Q4 2025.

  • Data Collective IV reported no remaining Roivant Sciences position as of Q4 2025 after selling out during the quarter.
  • Data Collective IV sold 3,875 Roivant Sciences shares in Q4 2025, an estimated $58.6K.
  • Data Collective IV first reported a position in Roivant Sciences in Q4 2022 and held it in 12 quarters.
  • Data Collective IV's Roivant Sciences position peaked at $206K in Q4 2022.
  • 396 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2025.

Based on Data Collective IV's 13F filing for Q4 2025, filed 17 Feb 2026.